Clean Air, Smart Cities, Healthy Hearts: Action on Air Pollution for Cardiovascular Health.

air pollution cardiovascular disease climate change cvd environmental health policy

Journal

Global heart
ISSN: 2211-8179
Titre abrégé: Glob Heart
Pays: England
ID NLM: 101584391

Informations de publication

Date de publication:
2021
Historique:
received: 12 08 2021
accepted: 25 08 2021
entrez: 25 10 2021
pubmed: 26 10 2021
medline: 18 11 2021
Statut: epublish

Résumé

More than twenty percent of all cardiovascular disease (CVD) deaths are caused by air pollution - more than three million deaths every year - and these numbers will continue to rise unless the global community takes action. Nine out of ten people worldwide breathe polluted air, which disproportionately affects those living in low-resource settings. The World Heart Federation (WHF) is committed to reducing the impact of air pollution on people's health and has made this a priority area of its global advocacy efforts. In pursuit of this goal, WHF has formed an Air Pollution Expert Group to inform action on air pollution for CVD health and recommend changes to public health policy. This policy paper lays out the health impacts of air pollution, examines its position on the global policy agenda, demonstrates its relevance to the cardiovascular community, and proposes actionable policy measures to mitigate this deadly risk factor to health. The paper considers the important roles to be played by the Members of WHF, including scientific societies and the physicians that constitute them, heart health foundations, and patient advocacy groups. The paper concludes with a detailed table of recommendations for the various sub-target groups at the global, national, local, and patient level.

Identifiants

pubmed: 34692385
doi: 10.5334/gh.1073
pmc: PMC8428302
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

61

Informations de copyright

Copyright: © 2021 The Author(s).

Déclaration de conflit d'intérêts

The authors have no competing interests to declare.

Références

Environ Pollut. 2017 Apr;223:102-110
pubmed: 28162801
Can Fam Physician. 2011 Aug;57(8):881-7, e280-7
pubmed: 21841106
Curr Environ Health Rep. 2015 Dec;2(4):440-50
pubmed: 26381684
Lancet. 2020 Oct 17;396(10258):1223-1249
pubmed: 33069327
Curr Environ Health Rep. 2017 Mar;4(1):61-67
pubmed: 28101730
Circulation. 2020 Dec 8;142(23):e411-e431
pubmed: 33150789
Acad Med. 2010 Jan;85(1):63-7
pubmed: 20042825
Sci Total Environ. 2013 Jan 15;443:184-93
pubmed: 23183229
Nat Rev Cardiol. 2020 Oct;17(10):656-672
pubmed: 32382149
Chest. 2019 Feb;155(2):417-426
pubmed: 30419237
Glob Heart. 2021 Jan 28;16(1):8
pubmed: 33598388
J Am Coll Cardiol. 2015 Jun 2;65(21):2279-87
pubmed: 26022815
Circulation. 2019 Apr 9;139(15):1766-1775
pubmed: 30700142
Circulation. 2020 Dec 8;142(23):e432-e447
pubmed: 33147996
J Am Coll Cardiol. 2019 Apr 30;73(16):2076-2085
pubmed: 31023432
PLoS One. 2017 Nov 27;12(11):e0188498
pubmed: 29176859
Circulation. 2018 Feb 13;137(7):725-742
pubmed: 29440198
Environ Health. 2013 Sep 11;12(1):77
pubmed: 24020494
N Engl J Med. 2017 Jun 29;376(26):2513-2522
pubmed: 28657878
Eur Heart J. 2015 Jan 7;36(2):83-93b
pubmed: 25492627
Am J Epidemiol. 2013 Sep 15;178(6):865-76
pubmed: 23887042
Environ Toxicol Pharmacol. 2010 Sep;30(2):175-80
pubmed: 21787649
Environ Health Perspect. 2010 Jun;118(6):783-9
pubmed: 20185385
Sci Total Environ. 2013 May 1;452-453:309-13
pubmed: 23523729
J Am Coll Cardiol. 2018 Oct 23;72(17):2054-2070
pubmed: 30336830
Circulation. 2010 Jun 1;121(21):2331-78
pubmed: 20458016
Glob Heart. 2012 Sep;7(3):243-7
pubmed: 25691487
Indoor Air. 2017 Sep;27(5):909-920
pubmed: 28170103
J Community Health. 2009 Feb;34(1):40-6
pubmed: 18821001
Int J Environ Res Public Health. 2015 May 19;12(5):5355-72
pubmed: 25996888

Auteurs

Michael Brauer (M)

The University of British Columbia, Institute for Health Metrics and Evaluation, University of Washington, CA.
University of Washington, US.

Narantuya Davaakhuu (N)

National Center for Public Health Mongolia, MN.

Maria Consuelo Escamilla Nuñez (MC)

Instituto Nacional de Salud Pública, MX.

Michael Hadley (M)

Mount Sinai, US.

Daniel Kass (D)

Vital Strategies, US.

Mark Miller (M)

Centre for Cardiovascular Sciences, University of Edinburgh, UK.

Dorairaj Prabhakaran (D)

Public Health Foundation India, IN.

Karen Sliwa (K)

Cape Heart Institute, Faculty of Health Sciences, University of Cape Town, ZA.

Ta-Chen Su (TC)

Department of Environmental and Occupational Medicine, National Taiwan University College of Medicine, TW.

Ilonca C H Vaartjes (ICH)

Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, NL.

Rajesh Vedanthan (R)

NYU Grossman School of Medicine, New York, US.

Jeremiah Mwangi (J)

World Heart Federation, CH.

Kelcey Armstrong-Walenczak (K)

World Heart Federation, CH.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH